Evidence map›Paper›PMID 19769484›Full record

ReviewAntioxidants & redox signaling2010

Novel insights into hydrogen sulfide--mediated cytoprotection.

John W Calvert, William A Coetzee, David J Lefer

Registry-linked trialAbstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01407172 (Hydrogen Sulfide and Peripheral Arterial Disease), which is not on this map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
10.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01407172 completednot on this mapstarted 2011, after this paper: background citation

Hydrogen Sulfide and Peripheral Arterial Disease

TypeobservationalSponsorLouisiana State University Health Sciences Center ShreveportRan2011 to 2012Enrolled252ConditionsPeripheral Arterial Disease
3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 311 citations in OpenAlex.

  1. Intracellular Crosstalk of the Gasotransmitter Trio (NO, CO, HInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Investigating the L-Glu-NMDA receptor-HFrontiers in pharmacology · 2024
    Article
  18. Article
  19. Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

John W CalvertDepartment of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
William A Coetzee
David J Lefer
Emory University · USUniversity School · US

Funding

Potassium Channels as Macromolecular ComplexesR01HL085820 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COETZEE, WILLIAM A, NEUBERT, THOMAS A · 2008 to 2013
$3.2M
Cardioprotective Actions of Hydrogen SulfideR01HL092141 · NHLBI · LSU HEALTH SCIENCES CENTER · PI LEFER, DAVID JOSEPH · 2009 to 2013
$1.9M
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY IN DIABETESR01HL060849 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI LEFER, DAVID JOSEPH · 1999 to 2008
$1.5M
NHLBI NIH HHS 2R01 HL-060849-09NHLBI NIH HHS 5R01 HL-092141-01NHLBI NIH HHS R01 HL-085820NHLBI NIH HHS R01 HL085820
6 · The paper itself

Abstract

Hydrogen sulfide (H(2)S) is a colorless, water soluble, flammable gas that has the characteristic smell of rotten eggs. Like other members of the gasotransmitter family (nitric oxide and carbon monoxide), H(2)S has traditionally been considered to be a highly toxic gas and environmental hazard. However, much like for nitric oxide and carbon monoxide, the initial negative perception of H(2)S has evolved with the discovery that H(2)S is produced enzymatically in mammals under normal conditions. As a result of this discovery, there has been a great deal of work to elucidate the physiological role of H(2)S. H(2)S is now recognized to be cytoprotective in various models of cellular injury. Specifically, it has been demonstrated that the acute administration of H(2)S, either prior to ischemia or at reperfusion, significantly ameliorates in vitro or in vivo myocardial and hepatic ischemia-reperfusion injury. These studies have also demonstrated a cardioprotective role for endogenous H(2)S. This review article summarizes the current body of evidence demonstrating the cytoprotective effects of H(2)S with an emphasis on the cardioprotective effects. This review also provides a detailed description of the current signaling mechanisms shown to be responsible for these cardioprotective actions.

Indexed as

Air PollutantsAnimalsAnti-Inflammatory AgentsAntioxidantsBlood VesselsCardiotonic AgentsCytoprotectionGarlicHeartHumansHydrogen SulfideIschemic Preconditioning, MyocardialKATP ChannelsMitochondriaProtein Kinase CReperfusion InjuryAir PollutantsAnti-Inflammatory AgentsAntioxidantsCardiotonic AgentsHydrogen SulfideKATP ChannelsProtein Kinase C

Identifiers

PMID19769484
PMCPMC2864658
OpenAlexW2091482008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.